Beijing Science Sun Pharmaceutical Co., Ltd. (SHE:300485)
China
· Delayed Price · Currency is CNY 11.22
+0.41 (3.79%)
At close: Mar 10, 2026
SHE:300485 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 5,404 | 3,376 | 5,101 | 5,770 | 6,353 | 7,109 | Upgrade
|
| Market Cap Growth | 55.19% | -33.80% | -11.60% | -9.17% | -10.64% | 62.97% | Upgrade
|
| Enterprise Value | 3,794 | 1,875 | 4,044 | 4,529 | 5,091 | 5,774 | Upgrade
|
| Last Close Price | 11.22 | 7.01 | 10.56 | 11.85 | 12.86 | 14.31 | Upgrade
|
| PE Ratio | 65.93 | - | 49.56 | 28.19 | 15.79 | 45.90 | Upgrade
|
| Forward PE | - | 27.14 | 27.14 | 27.14 | 27.14 | 27.14 | Upgrade
|
| PS Ratio | 13.44 | 8.11 | 10.70 | 7.86 | 6.05 | 6.50 | Upgrade
|
| PB Ratio | 1.57 | 1.00 | 1.47 | 1.69 | 1.94 | 2.50 | Upgrade
|
| P/TBV Ratio | 1.62 | 1.03 | 1.52 | 1.75 | 2.01 | 2.61 | Upgrade
|
| P/FCF Ratio | - | 96.89 | - | 85.93 | 46.25 | 48.73 | Upgrade
|
| P/OCF Ratio | 88.66 | 24.83 | 240.48 | 52.25 | 34.66 | 26.96 | Upgrade
|
| EV/Sales Ratio | 9.43 | 4.50 | 8.49 | 6.17 | 4.85 | 5.28 | Upgrade
|
| EV/EBITDA Ratio | 68.72 | 27.06 | 468.15 | 63.22 | 33.70 | 35.96 | Upgrade
|
| EV/EBIT Ratio | - | 83.53 | - | 186.82 | 53.36 | 46.72 | Upgrade
|
| EV/FCF Ratio | -128.84 | 53.80 | - | 67.45 | 37.06 | 39.58 | Upgrade
|
| Net Debt / Equity Ratio | -0.48 | -0.46 | -0.34 | -0.33 | -0.39 | -0.41 | Upgrade
|
| Net Debt / EBITDA Ratio | -29.81 | -22.69 | -135.86 | -15.66 | -8.58 | -7.35 | Upgrade
|
| Net Debt / FCF Ratio | 55.53 | -45.10 | 37.02 | -16.70 | -9.43 | -8.09 | Upgrade
|
| Asset Turnover | 0.11 | 0.12 | 0.13 | 0.21 | 0.33 | 0.38 | Upgrade
|
| Inventory Turnover | 1.71 | 1.52 | 1.44 | 1.62 | 1.29 | 1.08 | Upgrade
|
| Quick Ratio | 20.86 | 19.79 | 23.91 | 16.15 | 15.75 | 9.66 | Upgrade
|
| Current Ratio | 21.80 | 20.86 | 26.30 | 17.62 | 17.30 | 10.93 | Upgrade
|
| Return on Equity (ROE) | 2.18% | -2.24% | 2.80% | 6.05% | 12.88% | 5.44% | Upgrade
|
| Return on Assets (ROA) | 0.16% | 0.39% | -0.69% | 0.43% | 1.86% | 2.67% | Upgrade
|
| Return on Invested Capital (ROIC) | 0.39% | 1.09% | -1.37% | 0.90% | 4.70% | 6.72% | Upgrade
|
| Return on Capital Employed (ROCE) | 0.30% | 0.60% | -1.10% | 0.70% | 2.90% | 4.30% | Upgrade
|
| Earnings Yield | 1.50% | -2.04% | 2.02% | 3.55% | 6.33% | 2.18% | Upgrade
|
| FCF Yield | -0.54% | 1.03% | -0.62% | 1.16% | 2.16% | 2.05% | Upgrade
|
| Dividend Yield | - | - | 0.21% | 0.73% | 1.31% | 0.45% | Upgrade
|
| Payout Ratio | - | - | 40.22% | 39.50% | 7.78% | 19.38% | Upgrade
|
| Buyback Yield / Dilution | 4.35% | -0.35% | -2.93% | 0.58% | 1.07% | -0.96% | Upgrade
|
| Total Shareholder Return | 4.35% | -0.35% | -2.72% | 1.30% | 2.38% | -0.50% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.